Regional Health is involved in head and neck cancer research trials. Below is more information about the purpose and who the physician (principal investigator) is for each trial. For more in-depth information on the research studies, click the blue name which will lead you to the U.S. National Institute of Health website or call (605) 755-2300.
Phase III Study of Postoperative Radiation Therapy (IMRT) Cetxuimab for Locally-Advanced Resected Head and Neck Cancer
|To learn more, contact:
John T. Vucurevich Cancer Care Institute
Michael Swartz, MD